Articles

Filtered · 34

• Hurdle’s biomarker discovery engine unravels a novel biomarker for chronic inflammation in humans (InflammAge)

  

  Dani Martin-Herranz, PhD · CSO & Co-founder, Hurdle

  Published 30 January 2024

  Epigenetics & Aging

  

• Hurdle and Bayer Launch Strategic Partnership to Pioneer Precision Health in Aging

  

  Tom Stubbs, PhD · CEO, Hurdle

  Published 28 November 2023

  Epigenetics & Aging

  

• How to Choose the Right Software Architecture for Your Business?

  MG

  Milos Gavrilov

  Published 11 October 2023

  Diagnostics Infrastructure

  

• Medical Due Diligence Required for Each Test

  

  Dave Russell · VP of Compliance, Hurdle

  Published 28 September 2023

  Compliance & Regulations

  

• It's Never Been Easier to Test for Biological Age

  

  Dani Martin-Herranz, PhD · CSO & Co-founder, Hurdle

  Published 2 May 2023

  Epigenetics & Aging

  

• The Windsor Agreement: What it Might Mean for Remote Diagnostic Testing in the UK & EU

  

  Emma Stone · VP of Operations, Hurdle

  Published 28 February 2023

  Compliance & Regulations

  

• In-Clinic vs At-Home Health Testing: What Labs Should Know

  

  Tom Stubbs, PhD · CEO, Hurdle

  Published 16 February 2023

  Expert Insights

  

• Diagnostics as Service– A Game-Changer for Health Testing?

  

  Tom Stubbs, PhD · CEO, Hurdle

  Published 2 February 2023

  Diagnostics Infrastructure

  

• Why Hurdle: The Rationale Behind Our New Name

  

  Tom Stubbs, PhD · CEO, Hurdle

  Published 1 November 2022

  Industry News

  

• Beginning Your Epigenetic Testing Journey

  

  Tom Stubbs, PhD · CEO, Hurdle

  Published 19 April 2021

  Epigenetics & Aging